Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic model
- 1 February 2007
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 413 (2), 168-172
- https://doi.org/10.1016/j.neulet.2006.11.075
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental EvidencesCurrent Drug Therapy, 2006
- Microdialysis in Drug DiscoveryCurrent Drug Discovery Technologies, 2004
- Astrocytic response in hippocampus and cerebral cortex in an experimental epilepsy model.Neurochemical Research, 2004
- Validation of a new intraarterial microdialysis shunt probe for the estimation of pharmacokinetic parametersJournal of Pharmaceutical and Biomedical Analysis, 2003
- Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodentsPharmacology Biochemistry and Behavior, 2002
- EpilepsyNew England Journal of Medicine, 2001
- P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugsInt. Journal of Clinical Pharmacology and Therapeutics, 2000
- Modification of [3H]MK801 binding to rat brain NMDA receptors after the administration of a convulsant drug and an adenosine analogue: a quantitative autoradiographic study.Neurochemical Research, 1998
- Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in ratsBrain Research, 1996
- Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoproteinBiochemical Pharmacology, 1992